Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1992 1
2002 3
2003 8
2004 4
2005 7
2006 3
2007 5
2008 4
2009 4
2010 9
2011 3
2012 10
2013 6
2014 7
2015 2
2016 4
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Evans RR, Joish VN, Eckert L, Graham NM, Stahl N, Yancopoulos GD, Louis-Tisserand M, Teper A. Wenzel S, et al. Among authors: sutherland er. Lancet. 2016 Jul 2;388(10039):31-44. doi: 10.1016/S0140-6736(16)30307-5. Epub 2016 Apr 27. Lancet. 2016. PMID: 27130691 Clinical Trial.
Nocturnal asthma.
Sutherland ER. Sutherland ER. J Allergy Clin Immunol. 2005 Dec;116(6):1179-86; quiz 1187. doi: 10.1016/j.jaci.2005.09.028. Epub 2005 Nov 8. J Allergy Clin Immunol. 2005. PMID: 16337443 Review.
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Thaçi D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NM, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M. Thaçi D, et al. Among authors: sutherland er. Lancet. 2016 Jan 2;387(10013):40-52. doi: 10.1016/S0140-6736(15)00388-8. Epub 2015 Oct 8. Lancet. 2016. PMID: 26454361 Clinical Trial.
Asthma outcomes: symptoms.
Krishnan JA, Lemanske RF Jr, Canino GJ, Elward KS, Kattan M, Matsui EC, Mitchell H, Sutherland ER, Minnicozzi M. Krishnan JA, et al. Among authors: sutherland er. J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S124-35. doi: 10.1016/j.jaci.2011.12.981. J Allergy Clin Immunol. 2012. PMID: 22386505 Free PMC article. Review.
Obesity and asthma.
Beuther DA, Weiss ST, Sutherland ER. Beuther DA, et al. Among authors: sutherland er. Am J Respir Crit Care Med. 2006 Jul 15;174(2):112-9. doi: 10.1164/rccm.200602-231PP. Epub 2006 Apr 20. Am J Respir Crit Care Med. 2006. PMID: 16627866 Free PMC article. Review.
Linking obesity and asthma.
Sutherland ER. Sutherland ER. Ann N Y Acad Sci. 2014 Apr;1311:31-41. doi: 10.1111/nyas.12357. Epub 2014 Feb 12. Ann N Y Acad Sci. 2014. PMID: 24517401 Free article. Review.
Obesity and asthma.
Sutherland ER. Sutherland ER. Immunol Allergy Clin North Am. 2008 Aug;28(3):589-602, ix. doi: 10.1016/j.iac.2008.03.003. Immunol Allergy Clin North Am. 2008. PMID: 18572109 Free PMC article. Review.
Obesity and asthma disease phenotypes.
Stream AR, Sutherland ER. Stream AR, et al. Among authors: sutherland er. Curr Opin Allergy Clin Immunol. 2012 Feb;12(1):76-81. doi: 10.1097/ACI.0b013e32834eca41. Curr Opin Allergy Clin Immunol. 2012. PMID: 22157152 Review.
Management of chronic obstructive pulmonary disease.
Sutherland ER, Cherniack RM. Sutherland ER, et al. N Engl J Med. 2004 Jun 24;350(26):2689-97. doi: 10.1056/NEJMra030415. N Engl J Med. 2004. PMID: 15215485 Review. No abstract available.
78 results